http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109536495-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate | 2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109536495-B |
| titleOfInvention | siRNA for inhibiting RTL1 gene expression and application thereof |
| abstract | The invention provides siRNA for inhibiting RTL1 gene expression and application thereof, wherein the siRNA is at least one of the following three siRNAs: RTL1-siRNA1, the nucleotide sequence of the sense strand is shown as SEQ ID NO.1, and the nucleotide sequence of the antisense strand is shown as SEQ ID NO. 2; RTL1-siRNA2, the nucleotide sequence of the sense strand is shown as SEQ ID NO.3, and the nucleotide sequence of the antisense strand is shown as SEQ ID NO. 4; RTL1-siRNA3, the nucleotide sequence of the sense strand is shown as SEQ ID NO.5, and the nucleotide sequence of the antisense strand is shown as SEQ ID NO. 6; the siRNA interferes with mouse RTL1 gene, and the interference efficiency on the transcription level reaches 87%; the siRNA can be applied to preparing products for preventing and/or treating muscular hypertrophy. |
| priorityDate | 2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.